Lee's Pharmaceutical, ScinoPharm Taiwan deal

Lee's and ScinoPharm partnered to develop, produce and commercialize fondaparinux, travoprost and bimatoprost in China. Fondaparinux is an antithrombotic that selectively inhibits

Read the full 227 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE